These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8036682)

  • 1. Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis.
    Neal RA; Murphy AG; Olliaro P; Croft SL
    Trans R Soc Trop Med Hyg; 1994; 88(2):223-5. PubMed ID: 8036682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran.
    Asilian A; Jalayer T; Nilforooshzadeh M; Ghassemi RL; Peto R; Wayling S; Olliaro P; Modabber F
    Bull World Health Organ; 2003; 81(5):353-9. PubMed ID: 12856053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M; Schuster BG; Ellis WY; Berman JD
    J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of 'Old World' cutaneous leishmaniasis with aminosidine ointment: results of an open study in London.
    Bryceson AD; Murphy A; Moody AH
    Trans R Soc Trop Med Hyg; 1994; 88(2):226-8. PubMed ID: 8036683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical treatment of cutaneous leishmaniasis in Belize: in vitro and in vivo studies with Leishmania mexicana.
    el-On J; Cawich F; Evans DA; Weinrauch L
    Int J Parasitol; 1993 Feb; 23(1):121-7. PubMed ID: 8468127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran.
    Asilian A; Jalayer T; Whitworth JA; Ghasemi RL; Nilforooshzadeh M; Olliaro P
    Am J Trop Med Hyg; 1995 Dec; 53(6):648-51. PubMed ID: 8561269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the topical treatment of experimental cutaneous leishmaniasis: the therapeutic effect of methyl benzethonium chloride and the aminoglycosides, gentamicin and paromomycin.
    Carter KC; Alexander J; Baillie AJ
    Ann Trop Med Parasitol; 1989 Jun; 83(3):233-9. PubMed ID: 2604461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical treatment of New and Old World cutaneous leishmaniasis in experimental animals.
    el-On J; Hamburger AD
    Trans R Soc Trop Med Hyg; 1987; 81(5):734-7. PubMed ID: 3449988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment.
    el-On J; Sulitzeanu A; Schnur LF
    Ann Trop Med Parasitol; 1991 Jun; 85(3):323-8. PubMed ID: 1746981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
    Stanimirović A; Stipić T; Skerlev M; Basta-Juzbasić A
    J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):214-7. PubMed ID: 10642059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.
    Hepburn NC; Tidman MJ; Hunter JA
    Trans R Soc Trop Med Hyg; 1994; 88(6):700-3. PubMed ID: 7886779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod.
    El-On J; Bazarsky E; Sneir R
    Exp Parasitol; 2007 Jun; 116(2):156-62. PubMed ID: 17306255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of paromomycin sulphate topical ointment as effective therapeutic agent in cutaneous leishmaniasis.
    Sahibzada NJ; Tareen AK; Khursheed T; Darr N
    J Pak Med Assoc; 1996 Mar; 46(3):53-5. PubMed ID: 8991348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis.
    Mussi SV; Fernandes AP; Ferreira LA
    Parasitol Res; 2007 May; 100(6):1221-6. PubMed ID: 17206508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin.
    Neva FA; Ponce C; Ponce E; Kreutzer R; Modabber F; Olliaro P
    Trans R Soc Trop Med Hyg; 1997; 91(4):473-5. PubMed ID: 9373659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran.
    Iraji F; Sadeghinia A
    Ann Trop Med Parasitol; 2005 Jan; 99(1):3-9. PubMed ID: 15701249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania major: histopathological responses before and after topical treatment in experimental animals.
    El-On J; Lang E; Kuperman O; Avinoach I
    Exp Parasitol; 1989 Feb; 68(2):144-54. PubMed ID: 2924878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
    Ben Salah A; Ben Messaoud N; Guedri E; Zaatour A; Ben Alaya N; Bettaieb J; Gharbi A; Belhadj Hamida N; Boukthir A; Chlif S; Abdelhamid K; El Ahmadi Z; Louzir H; Mokni M; Morizot G; Buffet P; Smith PL; Kopydlowski KM; Kreishman-Deitrick M; Smith KS; Nielsen CJ; Ullman DR; Norwood JA; Thorne GD; McCarthy WF; Adams RC; Rice RM; Tang D; Berman J; Ransom J; Magill AJ; Grogl M
    N Engl J Med; 2013 Feb; 368(6):524-32. PubMed ID: 23388004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
    Aguiar MG; Silva DL; Nunan FA; Nunan EA; Fernandes AP; Ferreira LA
    J Antimicrob Chemother; 2009 Dec; 64(6):1234-40. PubMed ID: 19825819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmaniasis.
    Soto J; Grogl M; Berman J; Olliaro P
    Trans R Soc Trop Med Hyg; 1994; 88(6):695-8. PubMed ID: 7886777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.